Conatus Pharmaceuticals Inc. (CNAT): From Top to Bottom

Conatus Pharmaceuticals Inc. (CNAT) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $5.03, up from yesterday’s close by 13.54%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Conatus Pharmaceuticals Inc. (CNAT) currently trades with a market capitalization of $152.91 Million. That value represents a market adjusting for revenues that have been growing by 39.14 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$33.38 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.2 on a per share basis this quarter. Perhaps, that suggests something about why 0.62% of the outstanding share supply is held by institutional investors.



Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Conatus Pharmaceuticals Inc. recorded a 52-week high of $7.95. It is now trading 2.92% off that level. The stock is trading $3.94 its 50-day moving average by -1.09%. The stock carved out a 52-week low down at $3.22.

In recent action, Conatus Pharmaceuticals Inc. (CNAT) has made a move of +29.31% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.11, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 8.65% with $28.96 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CNAT.

SHARE
Previous articleTaking a Fresh Look at Urban Outfitters, Inc. (URBN)
Next articleDrilling Down Into Frontier Communications Corporation (FTR)